Petra Stieber

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Disorders

Procedures

Enzyme-Linked Immunosorbent Assay

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Lenhard Miriam S; Mitterer Stefanie; Kümper Carolin; Stieber Petra; Mayr Doris; Ditsch Nina; Friese Klaus; Burges Alexander
Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort.
Lenhard S Miriam; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
Relapse and survival in early-stage ovarian cancer.
Herbst Andreas; Wallner Maike; Rahmig Konstanze; Stieber Petra; Crispin Alexander; Lamerz Rolf; Kolligs Frank T
Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Petra Stieber (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Lenhard Miriam S; Mitterer Stefanie; Kümper Carolin; Stieber Petra; Mayr Doris; Ditsch Nina; Friese Klaus; Burges Alexander
Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort.
European journal of obstetrics, gynecology, and reproductive biology 2009;145(2):189-94.
2009: Lenhard S Miriam; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
Relapse and survival in early-stage ovarian cancer.
Archives of gynecology and obstetrics 2009;280(1):71-7.
2009: Herbst Andreas; Wallner Maike; Rahmig Konstanze; Stieber Petra; Crispin Alexander; Lamerz Rolf; Kolligs Frank T
Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence.
European journal of gastroenterology & hepatology 2009;21(5):565-9.
2009: Graser A; Stieber P; Nagel D; Schäfer C; Horst D; Becker C R; Nikolaou K; Lottes A; Geisbüsch S; Kramer H; Wagner A C; Diepolder H; Schirra J; Roth H J; Seidel D; Göke B; Reiser M F; Kolligs F T
Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
Gut 2009;58(2):241-8.
2009: Lenhard Miriam S; Nehring Stefanie; Nagel Dorothea; Mayr Doris; Kirschenhofer Angela; Hertlein Linda; Friese Klaus; Stieber Petra; Burges Alexander
Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2009;47(5):537-42.
2008: Holdenrieder Stefan; Nagel Dorothea; Schalhorn Andreas; Heinemann Volker; Wilkowski Ralf; von Pawel Joachim; Raith Hannelore; Feldmann Knut; Kremer Andreas E; Müller Susanne; Geiger Sandra; Hamann Gerhard F; Seidel Dietrich; Stieber Petra
Clinical relevance of circulating nucleosomes in cancer.
Annals of the New York Academy of Sciences 2008;1137():180-9.
2008: Holdenrieder Stefan; Burges Alexander; Reich Oliver; Spelsberg Fritz W; Stieber Petra
DNA integrity in plasma and serum of patients with malignant and benign diseases.
Annals of the New York Academy of Sciences 2008;1137():162-70.
2008: De Toni Enrico N; Thieme Susanne E; Herbst Andreas; Behrens Andrea; Stieber Petra; Jung Andreas; Blum Helmut; Göke Burkhard; Kolligs Frank T
OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(15):4713-8.
2008: Lenhard Miriam S; Burges Alexander; Johnson Thorsten R C; Stieber Petra; Kümper Carolin; Ditsch Nina; Linke Rainer; Friese Klaus
PET-CT in recurrent ovarian cancer: impact on treatment planning.
Anticancer research 2008;28(4C):2303-8.
2008: Holdenrieder Stefan; Kolligs Frank T; Stieber Petra
New horizons for diagnostic applications of circulating nucleosomes in blood?
Clinical chemistry 2008;54(7):1104-6.
2008: Toth Bettina; Nieuwland Rienk; Liebhardt Susanne; Ditsch Nina; Steinig Kerstin; Stieber Petra; Rank Andreas; Göhring Peter; Thaler Christian J; Friese Klaus; Bauerfeind Ingo
Circulating microparticles in breast cancer patients: a comparative analysis with established biomarkers.
Anticancer research 2008;28(2A):1107-12.
2008: Blankenburg Florian; Hatz Rudolf; Nagel Dorothea; Ankerst Donna; Reinmiedl Judith; Gruber Christine; Seidel Dietrich; Stieber Petra
Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer: external validation of a prognostic score.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2008;29(4):272-7.
2008: Dresse Marie; Nagel Dorothea; Ganser Eva-Maria; Davis Gerard; Dowell Barry; Doss Robert; Stieber Petra
Dependence of TIMP-1 plasma levels on preanalytical specimen handling.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2008;29(1):35-40.
2007: Haug Alexander Robert; Schmidt Gerwin Paul; Klingenstein Annemarie; Heinemann Volker; Stieber Petra; Priebe Markus; la Fougère Christian; Becker Christoph; Hahn Klaus; Tiling Reinhold
F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers.
Journal of computer assisted tomography 2007;31(4):629-34.
2007: Holdenrieder Stefan; Eichhorn Peter; Beuers Ulrich; Samtleben Walter; Stieber Petra; Nagel Dorothea; Peterfi Andrea; Steinle Alexander; Salih Helmut Rainer
Soluble NKG2D ligands in hepatic autoimmune diseases and in benign diseases involved in marker metabolism.
Anticancer research 2007;27(4A):2041-5.
2007: Laessig Dorit; Nagel Dorothea; Heinemann Volker; Untch Michael; Kahlert Steffen; Bauerfeind Ingo; Stieber Petra
Importance of CEA and CA 15-3 during disease progression in metastatic breast cancer patients.
Anticancer research 2007;27(4A):1963-8.
2007: Geiger Sandra; Holdenrieder Stefan; Stieber Petra; Hamann Gerhard F; Bruening Roland; Ma Jun; Nagel Dorothea; Seidel Dietrich
Nucleosomes as a new prognostic marker in early cerebral stroke.
Journal of neurology 2007;254(5):617-23.
2007: Boeck Stefan; Schulz Christoph; Stieber Petra; Holdenrieder Stefan; Weckbach Sabine; Heinemann Volker
Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: pretreatment levels or kinetics during chemotherapy?
Onkologie 2007;30(1-2):39-42.
2007: Lenhard Miriam; Kuemper Caroline; Ditsch Nina; Diebold Joachim; Stieber Petra; Friese Klaus; Burges Alexander
Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2007;45(5):657-61.
2006: Wallner Maike; Herbst Andreas; Behrens Andrea; Crispin Alexander; Stieber Petra; Göke Burkhard; Lamerz Rolf; Kolligs Frank T
Methylation of serum DNA is an independent prognostic marker in colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7347-52.
2006: Holdenrieder Stefan; Stieber Petra; Peterfi Andrea; Nagel Dorothea; Steinle Alexander; Salih Helmut Rainer
Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA.
Cancer immunology, immunotherapy : CII 2006;55(12):1584-9.
2006: Holdenrieder Stefan; Eichhorn Peter; Beuers Ulrich; Samtleben Walter; Schoenermarck Ulf; Zachoval Reinhart; Nagel Dorothea; Stieber Petra
Nucleosomal DNA fragments in autoimmune diseases.
Annals of the New York Academy of Sciences 2006;1075():318-27.
2006: Holdenrieder Stefan; Stieber Petra; VON Pawel Joachim; Raith Hannelore; Nagel Dorothea; Feldmann Knut; Seidel Dietrich
Early and specific prediction of the therapeutic efficacy in non-small cell lung cancer patients by nucleosomal DNA and cytokeratin-19 fragments.
Annals of the New York Academy of Sciences 2006;1075():244-57.
2006: Holdenrieder Stefan; Stieber Petra; Peterfi Andrea; Nagel Dorothea; Steinle Alexander; Salih Helmut Rainer
Soluble MICA in malignant diseases.
International journal of cancer. Journal international du cancer 2006;118(3):684-7.
2006: Ahlemann Martin; Schmitt Bärbel; Stieber Petra; Gires Olivier; Lang Stephan; Zeidler Reinhard
Evaluation of CK8-specific autoantibodies in carcinomas of distinct localisations.
Anticancer research 2006;26(1B):783-9.
2006: Boeck Stefan; Stieber Petra; Holdenrieder Stefan; Wilkowski Ralf; Heinemann Volker
Prognostic and therapeutic significance of carbohydrate antigen 19-9 as tumor marker in patients with pancreatic cancer.
Oncology 2006;70(4):255-64.
2006: Kremer Andreas; Holdenrieder Stefan; Stieber Petra; Wilkowski Ralf; Nagel Dorothea; Seidel Dietrich
Nucleosomes in colorectal cancer patients during radiochemotherapy.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2006;27(5):235-42.
2006: Mueller Susanne; Holdenrieder Stefan; Stieber Petra; Haferlach Torsten; Schalhorn Andreas; Braess Jan; Nagel Dorothea; Seidel Dietrich
Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments.
BMC cancer 2006;6():143.
2006: Geiger Sandra; Holdenrieder Stefan; Stieber Petra; Hamann Gerhard F; Bruening Roland; Ma Jun; Nagel Dorothea; Seidel Dietrich
Nucleosomes in serum of patients with early cerebral stroke.
Cerebrovascular diseases (Basel, Switzerland) 2006;21(1-2):32-7.
2005: Holdenrieder Stefan; Stieber Petra; Chan Lisa Y S; Geiger Sandra; Kremer Andreas; Nagel Dorothea; Lo Y M Dennis
Cell-free DNA in serum and plasma: comparison of ELISA and quantitative PCR.
Clinical chemistry 2005;51(8):1544-6.
2005: Holdenrieder Stefan; Mueller Susanne; Stieber Petra
Stability of nucleosomal DNA fragments in serum.
Clinical chemistry 2005;51(6):1026-9.
2005: Finek J; Holubec L; Topolcan O; Salvet J; Pikner R; Holdenrieder S; Stieber P; Lamerz R; Holubec Sen L; Svobodova S; Visokai V; Helmichova E
Clinical relevance of tumor markers for the control of chemotherapy.
Anticancer research 2005;25(3A):1655-8.
2005: Topolcan O; Holubec L; Finek J; Stieber P; Holdenrieder S; Lamerz R; Holubec Sen L; Svobodova S; Visokai V; Lipska L
Changes of thymidine kinase (TK) during adjuvant and palliative chemotherapy.
Anticancer research 2005;25(3A):1831-3.
2005: Holdenrieder Stefan; Holubec Lubos; Topolcan Ondrej; Finek Jindrich; Stieber Petra
Circulating nucleosomes and cytokeratin 19-fragments in patients with colorectal cancer during chemotherapy.
Anticancer research 2005;25(3A):1795-801.
2005: Holubec L; Topolcan O; Finek J; Holdenrieder S; Stieber P; Pesta M; Pikner R; Holubec Sen L; Sutnar A; Liska V; Svobodova S; Visokai V; Kormunda S
Markers of cellular adhesion in diagnosis and therapy control of colorectal carcinoma.
Anticancer research 2005;25(3A):1597-601.
2005: Stieber P; Heinemann V; Schalhorn A
[Tumor markers--how they should be applied]
MMW Fortschritte der Medizin 2005;147(20):35, 37-9.
2005: Kremer Andreas; Wilkowski Ralf; Holdenrieder Stefan; Nagel Dorothea; Stieber Petra; Seidel Dietrich
Nucleosomes in pancreatic cancer patients during radiochemotherapy.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2005;26(1):44-9.
2004: Holdenrieder Stefan; Stief Jutta; Bergner Albrecht; Gamarra Fernando; Mitlewski Anke; Nagel Dorothea; Huber Rudolph M; Stieber Petra
Nucleosomes indicate the in vitro radiosensitivity of irradiated bronchoepithelial and lung cancer cells.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2004;25(5-6):321-6.
2004: Holdenrieder Stefan; Stieber Petra; von Pawel Joachim; Raith Hannelore; Nagel Dorothea; Feldmann Knut; Seidel Dietrich
Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 1):5981-7.
2004: Holdenrieder Stefan; Lütjohann Dieter; Geiger Sandra; von Bergmann Klaus; Stieber Petra; Hamann Gerhard F
Does brain specific 24S-hydroxycholesterol in plasma indicate the disruption of the blood-brain barrier in patients with ischemic stroke?
Neuroscience letters 2004;368(2):201-4.
2004: Holdenrieder S; Stieber P
Apoptotic markers in cancer.
Clinical biochemistry 2004;37(7):605-17.
2004: Holdenrieder S; Stieber P
Therapy control in oncology by circulating nucleosomes.
Annals of the New York Academy of Sciences 2004;1022():211-6.
2004: Konecny Gottfried E; Meng Y Gloria; Untch Michael; Wang He-Jing; Bauerfeind Ingo; Epstein Melinda; Stieber Petra; Vernes Jean-Michel; Gutierrez Johnny; Hong Kyu; Beryt Malgorzata; Hepp Hermann; Slamon Dennis J; Pegram Mark D
Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(5):1706-16.
2003: Bergner A; Stief J; Holdenrieder S; Stieber P; Haimerl W; Passlick B; Waldschmidt A; Kummermehr J; Gamarra F; Huber R M
Effects of single-dose irradiation on bronchial epithelium: a comparison of BEAS 2B cell monolayers, human organ cultures, and Goettinger minipigs.
Radiation research 2003;160(6):647-54.
2003: Stemmler J; Stieber P; Szymala A M; Schalhorn A; Schermuly M M; Wilkowski R; Helmberger T; Lamerz R; Stoffregen C; Niebler K; Garbrecht M; Heinemann V
Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin?
Onkologie 2003;26(5):462-7.
2003: Mahnert Brigitte; Tauber Stephan; Kriegmair Martin; Nagel Dorothea; Holdenrieder Stefan; Hofmann Karin; Reiter Wolfgang; Schmeller Nikolaus; Stieber Petra
Measurements of complement factor H-related protein (BTA-TRAK assay) and nuclear matrix protein (NMP22 assay)--useful diagnostic tools in the diagnosis of urinary bladder cancer?
Clinical chemistry and laboratory medicine : CCLM / FESCC 2003;41(1):104-10.
2003: Muley Thomas; Ebert Werner; Stieber Petra; Raith Hannelore; Holdenrieder Stefan; Nagel Dorothea; Fürst Heinrich; Roth Hans-Jürgen; Luthe Hilmar; Blijenberg Bert G; Gurr Eberhard; Uhl Wolfgang; von Pawel Joachim; Drings Peter
Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2003;41(1):95-103.
2002: Lamerz R; Stieber P
[Treatment monitoring, recurrence detection, prognosis. Here's where tumor markers make good sense]
MMW Fortschritte der Medizin 2002;144(41):26-8, 30-2.
2002: Pauli C; Stieber P; Schmitt U M; Andratschke M; Hoffmann K; Wollenberg B
The significance of Tenascin-C serum level as tumor marker in squamous cell carcinoma of the head and neck.
Anticancer research 2002;22(5):3093-7.
2002: Ebeling F G; Stieber P; Untch M; Nagel D; Konecny G E; Schmitt U M; Fateh-Moghadam A; Seidel D
Serum CEA and CA 15-3 as prognostic factors in primary breast cancer.
British journal of cancer 2002;86(8):1217-22.
2001: Holdenrieder S; Stieber P; Bodenmüller H; Busch M; Von Pawel J; Schalhorn A; Nagel D; Seidel D
Circulating nucleosomes in serum.
Annals of the New York Academy of Sciences 2001;945():93-102.
2001: Holdenrieder S; Stieber P; Bodenmüller H; Fertig G; Fürst H; Schmeller N; Untch M; Seidel D
Nucleosomes in serum as a marker for cell death.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2001;39(7):596-605.
2001: Konecny G; Untch M; Pihan A; Kimmig R; Gropp M; Stieber P; Hepp H; Slamon D; Pegram M
Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(6):1743-9.
2001: Sreejayan N; Wittig B M; von Stillfried N; Hennicke M S; Meyer G; Stieber P; Lamerz R; von Ritter C
Human biliary mucin binds to E-selectin: a possible role in modulation of inflammation.
American journal of physiology. Gastrointestinal and liver physiology 2001;280(5):G1043-8.
2001: Holdenrieder S; Stieber P; Bodenmüller H; Busch M; Fertig G; Fürst H; Schalhorn A; Schmeller N; Untch M; Seidel D
Nucleosomes in serum of patients with benign and malignant diseases.
International journal of cancer. Journal international du cancer 2001;95(2):114-20.
2000: Holubec L; Topolcan O; Pikner R; Pecen L; Vaclavickova J; Wirthova M; Molacek J; Stieber P; Holdenrieder S; Sen L H; Finek J
The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.
Anticancer research 2000;20(6D):5237-44.
2000: Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Anticancer research 2000;20(6D):5195-8.
2000: Wichmann M W; Lau-Werner U; Müller C; Hornung H M; Stieber P; Schildberg F W;
Carcinoembryonic antigen for the detection of recurrent disease following curative resection of colorectal cancer.
Anticancer research 2000;20(6D):4953-5.
2000: Wichmann M W; Müller C; Lau-Werner U; Strauss T; Lang R A; Hornung H M; Stieber P; Schildberg F W
The role of carcinoembryonic antigen for the detection of recurrent disease following curative resection of large-bowel cancer.
Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie 2000;385(4):271-5.
2000: Schmitt U M; Stieber P; Jüngst D; Bilzer M; Wächtler M; Seidel D
[Is the alcoholic really sober, does the applicant drink, can the pilot still fly? CDT test often fails in reliability!]
MMW Fortschritte der Medizin 2000;142(12):46-7.
1999: Bilzer M; Schmitt U M; Stieber P; Seidel D; Gerbes A L
[Carbohydrate-deficient transferrin (CDT) is modified by iron status: further reservations regarding the value of a new alcohol marker?]
Zeitschrift für Gastroenterologie 1999;37(9):979-81.
1999: Holdenrieder S; Stieber P; Förg T; Kühl M; Schulz L; Busch M; Schalhorn A; Seidel D
Apoptosis in serum of patients with solid tumours.
Anticancer research 1999;19(4A):2721-4.
1999: Stieber P; Dienemann H; Schalhorn A; Schmitt U M; Reinmiedl J; Hofmann K; Yamaguchi K
Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
Anticancer research 1999;19(4A):2673-8.
1999: Stieber P; Zimmermann A; Reinmiedl J; Müller C; Hoffmann H; Dienemann H
CYFRA 21-1 in the early diagnosis of recurrent disease in non small cell lung carcinomas (NSCLC).
Anticancer research 1999;19(4A):2665-8.
1999: Mahnert B; Tauber S; Kriegmair M; Schmitt U M; Hasholzner U; Reiter W; Hofmann K; Schmeller N; Stieber P
BTA-TRAK--a useful diagnostic tool in urinary bladder cancer?
Anticancer research 1999;19(4A):2615-9.
1999: Ebeling F C; Schmitt U M; Untch M; Nagel D; Fateh-Moghadam A; Stieber P; Seidel D
Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysis.
Anticancer research 1999;19(4A):2545-50.
1999: Lamerz R; Runge M; Stieber P; Meissner E
Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases.
Anticancer research 1999;19(4A):2489-93.
1999: Hasholzner U; Stieber P; Reiter W; Zimmermann A; Hofmann K; Schalhorn A
CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancer.
Anticancer research 1999;19(4A):2477-80.
1999: Heinemann V; Schermuly M M; Stieber P; Schulz L; Jüngst D; Wilkowski R; Schalhorn A
CA19-9: a pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin.
Anticancer research 1999;19(4A):2433-5.
1999: Hasholzner U; Stieber P; Zimmermann A; Burges A; Hofmann K; Schmitt U M; Schmeller N; Schalhorn A
Nuclear mitotic apparatus protein (NuMA) in benign and malignant diseases.
Anticancer research 1999;19(4A):2415-20.
1998: Schmitt U M; Stieber P; Jüngst D; Bilzer M; Wächtler M; Heberger S; Seidel D
Carbohydrate-deficient transferrin is not a useful marker for the detection of chronic alcohol abuse.
European journal of clinical investigation 1998;28(8):615-21.
1998: Ritzke C; Stieber P; Untch M; Nagel D; Eiermann W; Fateh-Moghadam A
Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases.
Anticancer research 1998;18(2B):1243-9.
1997: Reiter W; Stieber P; Schmeller N; Nagel D; Fateh-Moghadam A
Alpha 1-antichymotrypsin-PSA (ACT-PSA): a useful marker in the differential diagnosis of benign hyperplasia and cancer of the prostate?
Anticancer research 1997;17(6D):4767-70.
1997: Reiter W; Stieber P; Schmeller N; Nagel D; Hofmann K; Fateh-Moghadam A
Total and free PSA: a methodical and clinical evaluation of five assays.
Anticancer research 1997;17(6D):4759-65.
1997: Schambeck C M; Stieber P; Schmeller N; Hofmann K; Pahl H; Fateh-Moghadam A
CYFRA 21-1 quantity measurement in the urine of patients with carcinoma of the urinary bladder and tract.
Anticancer research 1997;17(4B):3063-5.
1997: Hasholzner U; Stieber P; Meier W; Lamerz R
Value of HAMA--determination in clinical practice--an overview.
Anticancer research 1997;17(4B):3055-8.
1997: Poley S; Stieber P; Nüssler V; Pahl H; Fateh-Moghadam A
Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myeloma.
Anticancer research 1997;17(4B):3025-9.
1997: Poley S; Stieber P; Nüssler V; Pahl H; Fateh-Moghadam A
Evaluation of serum neural cell adhesion molecule as a prognostic marker in multiple myeloma.
Anticancer research 1997;17(4B):3021-4.
1997: Meier W; Baumgartner L; Stieber P; Hasholzner U; Fateh-Moghadam A
CA125 based diagnosis and therapy in recurrent ovarian cancer.
Anticancer research 1997;17(4B):3019-20.
1997: Reiter W; Stieber P; Schmeller N; Nagel D; Jansen H M; Schambeck C; Fabricius P G; Pahl H; Mattes M; Constabel H; Fateh-Moghadam A
The ratio of free to total prostate specific antigen: an advantageous addition in the differential diagnosis of benign hyperplasia and cancer of the prostate?
Anticancer research 1997;17(4B):2987-91.
1997: Waidelich R; Jansen H M; Stieber P; Schmeller N; Lamerz R; Werdan K; Fateh-Moghadam A
Screening for prostatic carcinoma with prostate specific antigen.
Anticancer research 1997;17(4B):2979-81.
1997: Meier W; Stieber P; Hasholzner U; Baumgartner L; Fateh-Moghadam A
Prognostic significance of squamous cell carcinoma (SCC) antigen in primary advanced and recurrent cervical carcinoma.
Anticancer research 1997;17(4B):2959-62.
1997: Meier W; Baumgartner L; Stieber P; Hasholzner U; Fateh-Moghadam A
Significance of tumor marker determinations in the primary therapy of ovarian cancer.
Anticancer research 1997;17(4B):2949-51.
1997: Meier W; Stieber P; Hasholzner U; Gropp M; Fateh-Moghadam A
Prognostic significance of CA125 in patients with ovarian cancer and secondary debulking surgery.
Anticancer research 1997;17(4B):2945-7.
1997: Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
Anticancer research 1997;17(4B):2935-8.
1997: von Ritter C; Eder M I; Stieber P; Lamerz R; Jüngst D; Strigl M; Meyer G; Reuter C; Paumgartner G
Biliary mucin secreted by cultured human gallbladder epithelial cells carries the epitope of CA 19-9.
Anticancer research 1997;17(4B):2931-4.
1997: Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Anticancer research 1997;17(4B):2903-6.
1997: Wollenberg B; Jan N V; Pitzke P; Reiter W; Stieber P
Anti-p53 antibodies in serum of smokers and head and neck cancer patients.
Anticancer research 1997;17(1A):413-8.
1997: Wollenberg B; Jan N; Sautier W; Hofmann K; Schmitt U M; Stieber P
Serum levels of intercellular adhesion molecule-1 in squamous cell carcinoma of the head and neck.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1997;18(2):88-94.
1997: Reiter W; Stieber P; Schmeller N; Nagel D; Schambeck C; Fateh-Moghadam A
Is free prostate-specific antigen helpful in the differential diagnosis of benign hyperplasia and cancer of the prostate?
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 1997;18(2):80-7.
1996: Stieber P; Schmeller N; Schambeck C; Hofmann K; Reiter W; Hasholzner U; Fateh-Moghadam A
Clinical relevance of CYFRA 21-1, TPA-IRMA and TPA-LIA-mat in urinary bladder cancer.
Anticancer research 1996;16(6B):3793-8.
1996: Wollenberg B; Jan V; Schmit U M; Hofmann K; Stieber P; Fateh-Moghadam A
CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer.
Anticancer research 1996;16(5B):3117-24.
1996: Schmitt U M; Stieber P; Hasholzner U; Pahl H; Hofmann K; Fateh-Moghadam A
Methodological and clinical evaluation of two automated enzymatic immunoassays as compared with a radioimmunoassay for neuron-specific enolase.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1996;34(8):679-82.
1996: Hasholzner U; Baumgartner L; Stieber P; Meier W; Reiter W; Pahl H; Fateh-Moghadam A
Clinical significance of the tumour markers CA 125 II and CA 72-4 in ovarian carcinoma.
International journal of cancer. Journal international du cancer 1996;69(4):329-34.
1995: Schambeck C M; Schmeller N; Stieber P; Jansen H M; Pahl H; Schneider W; Fateh-Moghadam A
Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancer.
Urology 1995;46(2):195-9.
1994: Hasholzner U; Baumgartner L; Stieber P; Meier W; Hofmann K; Fateh-Moghadam A
Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.
Anticancer research 1994;14(6B):2743-6.
1994: Stieber P; Dienemann H; Hasholzner U; Fabricius P G; Schambeck C; Weinzierl M; Poley S; Samtleben W; Hofmann K; Meier W
Comparison of CYFRA 21-1, TPA and TPS in lung cancer, urinary bladder cancer and benign diseases.
The International journal of biological markers 1994;9(2):82-8.
1993: Lamerz R; Stieber P; Fateh-Moghadam A
Serum marker combinations in human breast cancer (review).
In vivo (Athens, Greece) 1993;7(6B):607-13.
1993: Stieber P; Dienemann H; Hasholzner U; Müller C; Poley S; Hofmann K; Fateh-Moghadam A
Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and tissue polypeptide specific antigen (TPS) as tumour markers in lung cancer.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1993;31(10):689-94.
1993: Stieber P; Bodenmüller H; Banauch D; Hasholzner U; Dessauer A; Ofenloch-Hähnle B; Jaworek D; Fateh-Moghadam A
Cytokeratin 19 fragments: a new marker for non-small-cell lung cancer.
Clinical biochemistry 1993;26(4):301-4.
1993: Stieber P; Hasholzner U; Bodenmüller H; Nagel D; Sunder-Plassmann L; Dienemann H; Meier W; Fateh-Moghadam A
CYFRA 21-1. A new marker in lung cancer.
Cancer 1993;72(3):707-13.
1992: Stieber P; Nagel D; Ritzke C; Rössler N; Kirsch C M; Eiermann W; Fateh-Moghadam A
Significance of bone alkaline phosphatase, CA 15-3 and CEA in the detection of bone metastases during the follow-up of patients suffering from breast carcinoma.
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies 1992;30(12):809-14.
1992: Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
[Prognostic significance of the CA 125 half-life for the further outcome of ovarian cancer]
Geburtshilfe und Frauenheilkunde 1992;52(9):526-32.
1990: Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Schneider A; Hepp H
Squamous cell carcinoma antigen and carcinoembryonic antigen levels as prognostic factors for the response of cervical carcinoma to chemotherapy.
Gynecologic oncology 1990;38(1):6-11.
1989: Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H
[The course of squamous cell carcinoma antigen and CEA as prognostic criteria for response to chemotherapy in cervix cancer]
Geburtshilfe und Frauenheilkunde 1989;49(12):1050-5.
1989: Meier W; Eiermann W; Stieber P; Schneider A; Fateh-Moghadam A; Hepp H
Experiences with SCC antigen, a new tumor marker for cervical carcinoma.
European journal of cancer & clinical oncology 1989;25(11):1555-9.
1989: Meier W; Stieber P; Eiermann W; Schneider A; Fateh-Moghadam A; Hepp H
Serum levels of CA 125 and histological findings at second-look laparotomy in ovarian carcinoma.
Gynecologic oncology 1989;35(1):44-6.
1989: Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H
[Experiences with the squamous cell carcinoma antigen, a new tumor marker for cancer of the uterine cervix]
Geburtshilfe und Frauenheilkunde 1989;49(7):625-9.
1988: Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
[Serum CA 125 values and histologic findings at the time of second-look laparotomy in ovarian cancer]
Geburtshilfe und Frauenheilkunde 1988;48(5):331-3.
1987: Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
CA-125 in gynecological malignancies.
European journal of cancer & clinical oncology 1987;23(6):713-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Petra Stieber

Research Profile (preview)

Chemicals & Drugs

Concepts & Ideas

Disorders

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Petra Stieber (preview)

All Publications